{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:05:32Z","timestamp":1789916732113,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.autrev.2006.09.006","type":"journal-article","created":{"date-parts":[[2007,4,17]],"date-time":"2007-04-17T11:17:27Z","timestamp":1176808647000},"page":"278-285","source":"Crossref","is-referenced-by-count":47,"title":["Human parvovirus B19 infection and antiphospholipid antibodies"],"prefix":"10.1016","volume":"6","author":[{"given":"Philipp","family":"von Landenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartwig W.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Modrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2006.09.006_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(75)91074-0","article-title":"Parvovirus-like particles in human sera","volume":"1","author":"Cossart","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2006.09.006_bib2","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0140-6736(83)92152-9","article-title":"The human parvovirus, the cause of erythema infectiosum (fifth disease)?","volume":"1","author":"Anderson","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2006.09.006_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/infdis\/152.2.257","article-title":"Experimental parvoviral infection in humans","volume":"152","author":"Anderson","year":"1985","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.autrev.2006.09.006_bib4","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jcp.35.7.744","article-title":"Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period","volume":"35","author":"Anderson","year":"1982","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2006.09.006_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00428-002-0732-8","article-title":"Parvovirus B19: a pathogen responsible for more than hematologic disorders","volume":"442","author":"B\u00fcltmann","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1016\/j.autrev.2006.09.006_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/viro.1994.1460","article-title":"The structure of human parvovirus B19 at 8\u00a0\u00c5 resolution","volume":"203","author":"Agbandje-McKenna","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.autrev.2006.09.006_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/viro.1995.1418","article-title":"Most of the VP1-unique region of parvovirus B19 is on the capsid surface","volume":"211","author":"Kawase","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.autrev.2006.09.006_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/00222615-25-2-151","article-title":"The prevalence of antibody to human parvovirus B19 in England and Wales","volume":"25","author":"Cohen","year":"1988","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.autrev.2006.09.006_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/infdis\/154.3.383","article-title":"The role of parvovirus B19 in aplastic crisis and erythema infectiosum","volume":"154","author":"Chorba","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2006.09.006_bib10","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/JVI.61.8.2627-2630.1987","article-title":"Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures","volume":"61","author":"Ozawa","year":"1987","journal-title":"J Virol"},{"key":"10.1016\/j.autrev.2006.09.006_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0163-4453(98)90346-2","article-title":"The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis","volume":"37","author":"Yaegashi","year":"1998","journal-title":"J Infect"},{"key":"10.1016\/j.autrev.2006.09.006_bib12","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1046\/j.1537-2995.2002.00221.x","article-title":"Parvovirus B19 transmission by heat-treated clotting factor concentrates","volume":"42","author":"Bl\u00fcmel","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.autrev.2006.09.006_bib13","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1128\/JVI.67.6.3004-3009.1993","article-title":"Neutralizing linear epitopes of parvovirus B19 cluster in the VP1-unique and VP1-VP2-junction regions","volume":"67","author":"Saikawa","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.autrev.2006.09.006_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1099\/0022-1317-76-3-519","article-title":"Antibodies to parvovirus NS1 protein in infected individuals","volume":"76","author":"von Poblotzki","year":"1995","journal-title":"J Gen Virol"},{"key":"10.1016\/j.autrev.2006.09.006_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1386-6532(01)00247-5","article-title":"Chronic human parvovirus B19 infection in rheumatic diseases of childhood and adolescence","volume":"25","author":"Lehmann","year":"2002","journal-title":"J Clin Virol"},{"key":"10.1016\/j.autrev.2006.09.006_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0065-3101(24)00033-1","article-title":"Parvovirus infections in children and adults","volume":"46","author":"Cherry","year":"1999","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.autrev.2006.09.006_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/15513819609168684","article-title":"Polymerase chain reaction amplification of archival material for parvovirus B19 in children with transient erythroblastopenia of childhood","volume":"16","author":"Rogers","year":"1996","journal-title":"Pediatr Pathol Lab Med"},{"key":"10.1016\/j.autrev.2006.09.006_bib18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(01)05905-0","article-title":"Human parvovirus B19 infection associated with acute meningoencephalitis","volume":"358","author":"Barah","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2006.09.006_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM198707303170506","article-title":"Chronic bone marrow failure due to persistent B19 parvovirus infection","volume":"317","author":"Kurtzman","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2006.09.006_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/pd.940","article-title":"Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases","volume":"24","author":"Enders","year":"2004","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.autrev.2006.09.006_bib21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/ard.54.6.498","article-title":"Association between human parvovirus B19 infection and arthritis","volume":"54","author":"Cassinotti","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2006.09.006_bib22","first-page":"595","article-title":"Chronic fatigue syndrome and arthralgia following parvovirus B19 infection","volume":"29","author":"Kerr","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2006.09.006_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s100670200080","article-title":"Unusual localisation of chronic arthropathy in lumbar facet joints after parvovirus B19 infection","volume":"21","author":"Guillaume","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2006.09.006_bib24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/art.1780330901","article-title":"Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience","volume":"33","author":"Naides","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2006.09.006_bib25","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1172\/JCI111625","article-title":"Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro","volume":"74","author":"Young","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2006.09.006_bib26","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1128\/JVI.76.11.5395-5403.2002","article-title":"Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2","volume":"76","author":"Fu","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.autrev.2006.09.006_bib27","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1099\/0022-1317-82-12-3011","article-title":"Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue","volume":"82","author":"Kerr","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.autrev.2006.09.006_bib28","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/art.11038","article-title":"Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection","volume":"48","author":"Von Landenberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2006.09.006_bib29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2006.09.006_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/art.1780400115","article-title":"Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus","volume":"40","author":"Loizou","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2006.09.006_bib31","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<936::AID-IMMU936>3.0.CO;2-X","article-title":"Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties","volume":"28","author":"Lunardi","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2006.09.006_bib32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/ard.58.7.446","article-title":"Type II collagen is a target antigen of clonally expanded T cells in the synovium of patients with rheumatoid arthritis","volume":"58","author":"Sekine","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2006.09.006_bib33","first-page":"375","article-title":"Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis","volume":"17","author":"Serra","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2006.09.006_bib34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0002-9343(00)00561-1","article-title":"Transient anticardiolipin antibody syndrome in a patient with parvovirus B19 infection","volume":"109","author":"Reitblat","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2006.09.006_bib35","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1172\/JCI0212337","article-title":"Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome","volume":"109","author":"Blank","year":"2002","journal-title":"Clin Invest"},{"key":"10.1016\/j.autrev.2006.09.006_bib36","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.4049\/jimmunol.173.7.4675","article-title":"Human parvovirus B19 transgenic mice become susceptible to polyarthritis","volume":"173","author":"Takasawa","year":"2004","journal-title":"J Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899720600142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899720600142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T12:36:39Z","timestamp":1707827799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899720600142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S156899720600142X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2006.09.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}